ALK/SMAD Signaling in TGF beta-induced EC Permeability

TGFβ 诱导的 EC 通透性中的 ALK/SMAD 信号转导

基本信息

  • 批准号:
    7446642
  • 负责人:
  • 金额:
    $ 34.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-06-15 至 2010-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Disturbances in endothelial cell (EC) barrier regulation are a hallmark of lung inflammation, angiogenesis and cancer. EC permeability is regulated by a balance between contractile and tethering forces and critically depends upon the coordinate rearrangement of actin and microtubule cytoskeleton. Growing evidence indicates that inflammatory cytokines like TGF-B increase EC permeability in vitro and are involved in the increase in lung permeability in vivo. TGF-B elicits cellular effects on endothelium by engagement of TGF-B type I receptors, ALK1 and ALK5, following by activation of specific SMAD proteins that control the transcription of target genes. However, the involvement of ALK/SMAD signaling in TGF-B-induced cytoskeletal rearrangement and permeability are virtually unexplored. Our novel preliminary data indicated that specific depletion or inhibition of ALK5 and SMAD4 proteins significantly attenuated TGF-B decrease in transendothelial electrical resistance (TER) indicating the involvement of ALK/SMAD signaling in TGF-B-induced EC barrier compromise. Our recent data also indicate that TGF-B-induced decrease in TER and formation of paracellular gaps is tightly linked to F-actin stress fiber formation and increases in myosin light chain (MLC) phosphorylation indicating the involvement of contractile mechanisms in TGF-B-induced EC permeability. TGF-B-induced changes in EC cytoskeleton are critically dependent upon Rho GTPase activity and microtubule remodeling, but not Ca2+ signaling or MLC kinase activation. cAMP activation attenuates both TGF-B-induced decreases in TER and increases in MLC phosphorylation supporting the involvement of cAMP/PKA in barrier protection against TGF-B-induced EC permeability. In addition, TGF-B-induced EC stimulation activates p38 MAP kinase pathway, which also potentially can be involved in Rho-independent EC contractility via phosphorylation of key cytoskeletal proteins, like caldesmon and HSP-27. However, the link between activation of ALK/SMAD signaling and activation of EC contractility is unknown. In this proposal, we will explore the role of SMAD dependent and independent pathways involved in TGF-B-induced EC barrier dysfunction. Engagement of ALK1 and ALK5 receptors will be temporally linked with regulatory SMAD proteins phosphorylation and activation of Rho- and p38 MAPK-mediated EC cytoskeletal rearrangement and permeability. In Specific Aim 1, we will examine the link between TGF-B-induced Rho activation, ALK/SMAD signaling and EC permeability. In Specific Aim 2, we will examine the link between p38 MAPK-dependent pathways involved in TGF-B-induced EC barrier dysfunction and ALK/SMAD signaling. In Specific Aim 3, we will explore the molecular mechanisms by which cAMP/PKA protects against TGF-B-induced EC barrier failure focusing on the SMADs, Rho, p38 and cytoskeletal proteins as potential PKA targets. These studies will provide an understanding of novel signaling pathways involved in cytokine-mediated lung EC barrier regulation and promise new directions and targets for treatment of lung disorders.
描述(由申请方提供):内皮细胞(EC)屏障调节紊乱是肺部炎症、血管生成和癌症的标志。EC的渗透性是由收缩力和束缚力之间的平衡调节的,并且严重依赖于肌动蛋白和微管细胞骨架的协调重排。越来越多的证据表明,炎性细胞因子如TGF-β在体外增加EC通透性,并参与体内肺通透性的增加。TGF-β通过与TGF-β I型受体ALK 1和ALK 5结合,随后激活控制靶基因转录的特异性SMAD蛋白,从而增强对内皮的细胞效应。然而,ALK/SMAD信号转导在TGF-β诱导的细胞骨架重排和通透性中的参与几乎未被探索。我们的新的初步数据表明,特异性耗竭或抑制ALK 5和SMAD 4蛋白显著减弱了TGF-β跨内皮电阻(TER)的降低,表明ALK/SMAD信号转导参与了TGF-β诱导的EC屏障受损。我们最近的数据还表明,TGF-β诱导的TER减少和细胞旁间隙的形成与F-肌动蛋白应力纤维的形成和肌球蛋白轻链(MLC)磷酸化的增加密切相关,这表明TGF-β诱导的EC通透性的收缩机制的参与。TGF-β诱导的EC细胞骨架的变化主要依赖于Rho GT3活性和微管重塑,而不是Ca 2+信号或MLC激酶激活。cAMP激活减弱了TGF-β诱导的TER降低和MLC磷酸化增加,支持cAMP/PKA参与了针对TGF-β诱导的EC渗透性的屏障保护。此外,TGF-β诱导的EC刺激激活p38 MAP激酶途径,其也可能通过关键细胞骨架蛋白如钙调蛋白和HSP-27的磷酸化参与Rho非依赖性EC收缩性。然而,ALK/SMAD信号传导的激活与EC收缩性的激活之间的联系尚不清楚。在本研究中,我们将探讨SMAD依赖性和非依赖性通路在TGF-β诱导的EC屏障功能障碍中的作用。ALK 1和ALK 5受体的参与将与调节SMAD蛋白磷酸化和Rho和p38 MAPK介导的EC细胞骨架重排和渗透性的激活在时间上相关。在具体目标1中,我们将研究TGF-β诱导的Rho激活,ALK/SMAD信号转导和EC通透性之间的联系。在具体目标2中,我们将研究TGF-β诱导的EC屏障功能障碍和ALK/SMAD信号转导中涉及的p38 MAPK依赖性通路之间的联系。在具体目标3中,我们将探索cAMP/PKA保护TGF-β诱导的EC屏障失效的分子机制,重点关注SMADs,Rho,p38和细胞骨架蛋白作为潜在的PKA靶点。这些研究将提供一个新的信号转导途径参与尼古丁介导的肺EC屏障调节的理解,并承诺新的方向和肺部疾病的治疗目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALEXANDER D VERIN其他文献

ALEXANDER D VERIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALEXANDER D VERIN', 18)}}的其他基金

HDAC9 nuclear/cytoplasmic shuttling in pulmonary vascular endothelial barrier regulation
HDAC9核/细胞质穿梭在肺血管内皮屏障调节中的作用
  • 批准号:
    10597538
  • 财政年份:
    2022
  • 资助金额:
    $ 34.85万
  • 项目类别:
HDAC9 nuclear/cytoplasmic shuttling in pulmonary vascular endothelial barrier regulation
HDAC9核/细胞质穿梭在肺血管内皮屏障调节中的作用
  • 批准号:
    10446078
  • 财政年份:
    2022
  • 资助金额:
    $ 34.85万
  • 项目类别:
Rac1 Stimulation in Adenosine-Induced Barrier Protection
Rac1 刺激腺苷诱导的屏障保护
  • 批准号:
    8198064
  • 财政年份:
    2011
  • 资助金额:
    $ 34.85万
  • 项目类别:
Mini-plasmin: Pre-Clinical Evaluation of a Novel Thrombolytic Strategy for Stroke
微型纤溶酶:中风新型溶栓策略的临床前评估
  • 批准号:
    8215615
  • 财政年份:
    2011
  • 资助金额:
    $ 34.85万
  • 项目类别:
Endothelial Barrier Protection and Repair in Acute Lung Injury
急性肺损伤中的内皮屏障保护和修复
  • 批准号:
    8690947
  • 财政年份:
    2011
  • 资助金额:
    $ 34.85万
  • 项目类别:
Microtubule involvement in lung endothelial pathobiology
微管参与肺内皮病理学
  • 批准号:
    7347546
  • 财政年份:
    2007
  • 资助金额:
    $ 34.85万
  • 项目类别:
ATP in Lung Endothelial Barrier Enhancement
肺内皮屏障增强中的 ATP
  • 批准号:
    7026844
  • 财政年份:
    2006
  • 资助金额:
    $ 34.85万
  • 项目类别:
ATP in Lung Endothelial Barrier Enhancement
肺内皮屏障增强中的 ATP
  • 批准号:
    7540426
  • 财政年份:
    2006
  • 资助金额:
    $ 34.85万
  • 项目类别:
ATP in Lung Endothelial Barrier Enhancement
肺内皮屏障增强中的 ATP
  • 批准号:
    7435762
  • 财政年份:
    2006
  • 资助金额:
    $ 34.85万
  • 项目类别:
ATP in Lung Endothelial Barrier Enhancement
肺内皮屏障增强中的 ATP
  • 批准号:
    7330349
  • 财政年份:
    2006
  • 资助金额:
    $ 34.85万
  • 项目类别:

相似海外基金

Alveolar epithelial carbohydrate metabolism in acute lung injury
急性肺损伤时肺泡上皮碳水化合物代谢
  • 批准号:
    10320406
  • 财政年份:
    2018
  • 资助金额:
    $ 34.85万
  • 项目类别:
Metabolic Reprogramming of Recruited Alveolar Macrophages by Arginine In Acute Lung Injury
急性肺损伤中精氨酸对募集的肺泡巨噬细胞的代谢重编程
  • 批准号:
    10191011
  • 财政年份:
    2018
  • 资助金额:
    $ 34.85万
  • 项目类别:
Alveolar epithelial carbohydrate metabolism in acute lung injury
急性肺损伤时肺泡上皮碳水化合物代谢
  • 批准号:
    10080101
  • 财政年份:
    2018
  • 资助金额:
    $ 34.85万
  • 项目类别:
Metabolic Reprogramming of Recruited Alveolar Macrophages by Arginine In Acute Lung Injury
急性肺损伤中精氨酸对募集的肺泡巨噬细胞的代谢重编程
  • 批准号:
    10377415
  • 财政年份:
    2018
  • 资助金额:
    $ 34.85万
  • 项目类别:
Metabolic Reprogramming of Recruited Alveolar Macrophages by Arginine In Acute Lung Injury
急性肺损伤中精氨酸对募集的肺泡巨噬细胞的代谢重编程
  • 批准号:
    9886259
  • 财政年份:
    2018
  • 资助金额:
    $ 34.85万
  • 项目类别:
Effects of positional changes on alveolar dynamics and respiratory mechanics in rats with and without acute lung injury.
位置变化对有或没有急性肺损伤的大鼠肺泡动力学和呼吸力学的影响。
  • 批准号:
    310521225
  • 财政年份:
    2016
  • 资助金额:
    $ 34.85万
  • 项目类别:
    Research Grants
Regulation of alveolar epithelial homeostasis in acute lung injury
急性肺损伤中肺泡上皮稳态的调节
  • 批准号:
    9544670
  • 财政年份:
    2012
  • 资助金额:
    $ 34.85万
  • 项目类别:
Regulation of alveolar epithelial homeostasis in acute lung injury
急性肺损伤中肺泡上皮稳态的调节
  • 批准号:
    9000737
  • 财政年份:
    2012
  • 资助金额:
    $ 34.85万
  • 项目类别:
Regulation of alveolar epithelial homeostasis in acute lung injury
急性肺损伤中肺泡上皮稳态的调节
  • 批准号:
    8610349
  • 财政年份:
    2012
  • 资助金额:
    $ 34.85万
  • 项目类别:
Regulatory T Cell Modulation of the Alveolar Epithelium in Acute Lung Injury
急性肺损伤中肺泡上皮的调节性 T 细胞调节
  • 批准号:
    8396464
  • 财政年份:
    2012
  • 资助金额:
    $ 34.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了